Syndax Pharmaceuticals Inc short interest in 2025
In 2025, Syndax Pharmaceuticals Inc's disclosed short interest ran from 26.30% of shares outstanding on 15 Jan 2025 to 25.97% on 31 Dec 2025, a change of -0.33 percentage points. The year's high was 29.48% on 14 Nov 2025 and its low 22.12% on 14 Mar 2025, averaging 25.99% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.21 days on 31 Dec 2025. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 26.30% (15 Jan 2025)
- End of year
- 25.97% (31 Dec 2025)
- Change
- -0.33 pp
- High
- 29.48% (14 Nov 2025)
- Low
- 22.12% (14 Mar 2025)
- Average
- 25.99%
- Highest days to cover
- 18.21 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 26.30% | 11.55 | |
| 31 Jan 2025 | 26.09% | 9.95 | |
| 14 Feb 2025 | 25.33% | 8.55 | |
| 28 Feb 2025 | 22.57% | 8.78 | |
| 14 Mar 2025 | 22.12% | 8.53 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 22.75% | 13.69 | |
| 15 Apr 2025 | 24.88% | 9.32 | |
| 15 May 2025 | 25.26% | 6.49 | 10-Q filed, results (8-K) |
| 30 May 2025 | 26.89% | 8.60 | |
| 13 Jun 2025 | 25.57% | 15.40 | |
| 30 Jun 2025 | 27.74% | 10.65 | |
| 15 Jul 2025 | 27.53% | 13.26 | |
| 31 Jul 2025 | 27.78% | 13.62 | |
| 15 Aug 2025 | 23.92% | 5.62 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 24.28% | 9.76 | |
| 15 Sep 2025 | 26.86% | 12.77 | |
| 30 Sep 2025 | 26.48% | 10.98 | |
| 15 Oct 2025 | 25.57% | 10.96 | |
| 31 Oct 2025 | 29.16% | 5.92 | |
| 14 Nov 2025 | 29.48% | 7.59 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 29.02% | 10.65 | |
| 15 Dec 2025 | 26.26% | 12.48 | |
| 31 Dec 2025 | 25.97% | 18.21 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.